ad image

ADC

1 / 1
Axcynsis Therapeutics
FDA

Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65 Powered by AxcynDOT™ Technology

Axcynsis Therapeutics

PR-01-25-NI-19Jan 16, 2025
The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions
CDMO

The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions

Hyung-il Lee, Ph.D.

GBI

PAO-11-24-CL-09Dec 20, 2024
Chime Biologics
ADC

Chime Biologics and Waterstone Jointly Develop and Manufacture Antibody-Drug Conjugate (ADC)

Chime Biologics

PR-10-24-NI-91Nov 12, 2024
World ADC
ADC

World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda

World ADC

PR-10-24-NI-37Oct 10, 2024
1 / 1